Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Denmark | 72 | 2024 | 777 | 4.850 |
Why?
|
Mendelian Randomization Analysis | 23 | 2024 | 1044 | 4.190 |
Why?
|
Hypothyroidism | 12 | 2024 | 665 | 3.370 |
Why?
|
Myeloproliferative Disorders | 16 | 2024 | 616 | 3.310 |
Why?
|
Transferrin | 13 | 2024 | 283 | 3.060 |
Why?
|
Hemochromatosis | 13 | 2024 | 175 | 2.980 |
Why?
|
Hyperthyroidism | 7 | 2024 | 292 | 2.670 |
Why?
|
Thyroxine | 14 | 2024 | 665 | 2.630 |
Why?
|
Ferritins | 10 | 2024 | 601 | 2.480 |
Why?
|
Milk | 6 | 2018 | 436 | 2.290 |
Why?
|
Lactase | 7 | 2018 | 72 | 2.180 |
Why?
|
Thrombocythemia, Essential | 6 | 2024 | 114 | 2.150 |
Why?
|
Polycythemia Vera | 9 | 2024 | 160 | 2.100 |
Why?
|
Thyroid Gland | 10 | 2024 | 1170 | 2.060 |
Why?
|
Calreticulin | 8 | 2024 | 115 | 2.010 |
Why?
|
Hidradenitis Suppurativa | 14 | 2022 | 176 | 1.840 |
Why?
|
Thyrotropin | 14 | 2024 | 834 | 1.760 |
Why?
|
Janus Kinase 2 | 14 | 2024 | 562 | 1.720 |
Why?
|
Iodide Peroxidase | 7 | 2024 | 295 | 1.530 |
Why?
|
Iron Overload | 8 | 2023 | 245 | 1.400 |
Why?
|
Primary Myelofibrosis | 4 | 2024 | 209 | 1.250 |
Why?
|
Suburban Population | 7 | 2023 | 54 | 1.230 |
Why?
|
Thyroid Hormones | 3 | 2020 | 408 | 1.100 |
Why?
|
Diabetes Mellitus, Type 2 | 16 | 2024 | 12246 | 1.080 |
Why?
|
Iron | 11 | 2024 | 1812 | 1.080 |
Why?
|
Psoriasis | 10 | 2022 | 925 | 1.010 |
Why?
|
Suburban Health | 4 | 2017 | 11 | 0.970 |
Why?
|
Diabetes Mellitus, Type 1 | 12 | 2024 | 3446 | 0.970 |
Why?
|
Autoantibodies | 6 | 2023 | 2115 | 0.920 |
Why?
|
Lactose Intolerance | 3 | 2018 | 28 | 0.870 |
Why?
|
Acne Vulgaris | 3 | 2018 | 352 | 0.850 |
Why?
|
Strabismus | 3 | 2022 | 320 | 0.840 |
Why?
|
Graves Ophthalmopathy | 2 | 2022 | 135 | 0.840 |
Why?
|
Dairy Products | 4 | 2019 | 490 | 0.830 |
Why?
|
Anemia, Pernicious | 1 | 2022 | 16 | 0.820 |
Why?
|
Wet Macular Degeneration | 1 | 2024 | 165 | 0.770 |
Why?
|
Guanosine | 5 | 2024 | 43 | 0.740 |
Why?
|
Mortality | 5 | 2024 | 2908 | 0.740 |
Why?
|
Oxidative Stress | 11 | 2024 | 3139 | 0.730 |
Why?
|
Electrocardiography | 15 | 2024 | 6408 | 0.710 |
Why?
|
Nucleosides | 1 | 2021 | 130 | 0.700 |
Why?
|
Genotype | 19 | 2024 | 13036 | 0.690 |
Why?
|
Kidney | 7 | 2023 | 7073 | 0.670 |
Why?
|
Birth Weight | 4 | 2021 | 2123 | 0.660 |
Why?
|
Bruch Membrane | 2 | 2016 | 65 | 0.650 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2021 | 193 | 0.640 |
Why?
|
Retinal Drusen | 2 | 2016 | 78 | 0.630 |
Why?
|
Vaginal Birth after Cesarean | 1 | 2019 | 65 | 0.630 |
Why?
|
Goiter | 1 | 2019 | 86 | 0.620 |
Why?
|
Hemostasis | 1 | 2021 | 467 | 0.620 |
Why?
|
Middle Aged | 97 | 2024 | 223267 | 0.620 |
Why?
|
Cross-Sectional Studies | 41 | 2024 | 26309 | 0.610 |
Why?
|
Female | 120 | 2024 | 396532 | 0.610 |
Why?
|
Allostasis | 3 | 2024 | 76 | 0.610 |
Why?
|
Humans | 177 | 2024 | 766812 | 0.610 |
Why?
|
Cataract | 1 | 2024 | 837 | 0.600 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2021 | 557 | 0.600 |
Why?
|
Prediabetic State | 3 | 2020 | 547 | 0.600 |
Why?
|
Eye Diseases, Hereditary | 2 | 2016 | 124 | 0.590 |
Why?
|
Aged | 80 | 2024 | 171344 | 0.590 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2024 | 16044 | 0.590 |
Why?
|
Male | 113 | 2024 | 364154 | 0.590 |
Why?
|
Blood Cells | 1 | 2019 | 309 | 0.580 |
Why?
|
Erectile Dysfunction | 1 | 2021 | 437 | 0.570 |
Why?
|
Glomerular Filtration Rate | 4 | 2023 | 2232 | 0.560 |
Why?
|
Appendicitis | 1 | 2024 | 680 | 0.560 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2021 | 364 | 0.560 |
Why?
|
Macular Degeneration | 1 | 2024 | 1015 | 0.550 |
Why?
|
Abortion, Spontaneous | 2 | 2021 | 536 | 0.530 |
Why?
|
Maternal Age | 1 | 2019 | 804 | 0.530 |
Why?
|
Thyroid Function Tests | 4 | 2021 | 289 | 0.530 |
Why?
|
Adult | 85 | 2024 | 223305 | 0.520 |
Why?
|
Arrhythmias, Cardiac | 5 | 2023 | 2257 | 0.510 |
Why?
|
Genome-Wide Association Study | 16 | 2024 | 12808 | 0.500 |
Why?
|
Triiodothyronine | 6 | 2024 | 493 | 0.500 |
Why?
|
Aged, 80 and over | 37 | 2024 | 59548 | 0.500 |
Why?
|
Smoking | 5 | 2019 | 9077 | 0.490 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1791 | 0.480 |
Why?
|
Biological Specimen Banks | 4 | 2024 | 787 | 0.480 |
Why?
|
Population Surveillance | 5 | 2019 | 2594 | 0.480 |
Why?
|
Spirometry | 1 | 2018 | 929 | 0.470 |
Why?
|
Arthritis, Psoriatic | 1 | 2017 | 219 | 0.470 |
Why?
|
Inflammation | 10 | 2024 | 10863 | 0.460 |
Why?
|
RNA | 6 | 2024 | 2715 | 0.460 |
Why?
|
Risk Factors | 34 | 2024 | 74889 | 0.460 |
Why?
|
Hip Fractures | 3 | 2018 | 996 | 0.450 |
Why?
|
Depressive Disorder | 3 | 2022 | 3715 | 0.450 |
Why?
|
Iron, Dietary | 4 | 2023 | 148 | 0.450 |
Why?
|
Specimen Handling | 2 | 2016 | 706 | 0.450 |
Why?
|
beta-Thalassemia | 1 | 2016 | 234 | 0.440 |
Why?
|
Chemistry, Clinical | 3 | 2022 | 64 | 0.430 |
Why?
|
Educational Status | 3 | 2017 | 2510 | 0.430 |
Why?
|
Thyroidectomy | 1 | 2019 | 912 | 0.420 |
Why?
|
Registries | 6 | 2024 | 8352 | 0.420 |
Why?
|
Genetic Predisposition to Disease | 13 | 2023 | 18076 | 0.420 |
Why?
|
Interferon-alpha | 5 | 2024 | 910 | 0.410 |
Why?
|
Laparoscopy | 1 | 2024 | 2038 | 0.400 |
Why?
|
Creatinine | 5 | 2023 | 1917 | 0.390 |
Why?
|
Metabolic Diseases | 1 | 2018 | 686 | 0.390 |
Why?
|
Prenatal Care | 1 | 2019 | 1158 | 0.390 |
Why?
|
Case-Control Studies | 25 | 2023 | 22248 | 0.390 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1560 | 0.380 |
Why?
|
Young Adult | 38 | 2024 | 59939 | 0.380 |
Why?
|
Atrial Fibrillation | 3 | 2019 | 5182 | 0.380 |
Why?
|
Goals | 1 | 2017 | 717 | 0.380 |
Why?
|
Self Report | 6 | 2024 | 3771 | 0.380 |
Why?
|
Kidney Diseases | 2 | 2020 | 2101 | 0.380 |
Why?
|
Long QT Syndrome | 1 | 2016 | 473 | 0.370 |
Why?
|
Diabetes Mellitus | 8 | 2024 | 5888 | 0.370 |
Why?
|
Social Class | 2 | 2017 | 2007 | 0.370 |
Why?
|
Th17 Cells | 1 | 2017 | 790 | 0.370 |
Why?
|
Maternal Exposure | 1 | 2018 | 1096 | 0.370 |
Why?
|
Mutation | 15 | 2024 | 30214 | 0.350 |
Why?
|
Myocardial Ischemia | 2 | 2015 | 2131 | 0.350 |
Why?
|
Lymphocytes | 3 | 2024 | 2606 | 0.340 |
Why?
|
Albuminuria | 3 | 2023 | 659 | 0.340 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2744 | 0.330 |
Why?
|
Personal Satisfaction | 1 | 2014 | 642 | 0.330 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2018 | 856 | 0.330 |
Why?
|
Liver Diseases | 3 | 2024 | 1303 | 0.310 |
Why?
|
Hypertension | 7 | 2020 | 8616 | 0.310 |
Why?
|
Rural Population | 6 | 2020 | 2321 | 0.310 |
Why?
|
Antidepressive Agents | 3 | 2022 | 2903 | 0.300 |
Why?
|
Bone Density | 2 | 2018 | 3491 | 0.300 |
Why?
|
Biological Products | 1 | 2017 | 948 | 0.300 |
Why?
|
Diabetes, Gestational | 1 | 2018 | 1263 | 0.300 |
Why?
|
Income | 1 | 2017 | 1876 | 0.300 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15652 | 0.300 |
Why?
|
Antirheumatic Agents | 1 | 2017 | 1383 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2306 | 0.290 |
Why?
|
Rural Health | 2 | 2020 | 302 | 0.290 |
Why?
|
Phenotype | 3 | 2021 | 16722 | 0.280 |
Why?
|
Life Style | 2 | 2017 | 3926 | 0.280 |
Why?
|
Adipokines | 2 | 2019 | 308 | 0.280 |
Why?
|
Hydroxyurea | 3 | 2023 | 284 | 0.280 |
Why?
|
Polyethylene Glycols | 2 | 2024 | 1189 | 0.270 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3235 | 0.260 |
Why?
|
Heart Conduction System | 3 | 2022 | 1008 | 0.260 |
Why?
|
Health Surveys | 4 | 2018 | 4055 | 0.260 |
Why?
|
General Practice | 2 | 2017 | 101 | 0.260 |
Why?
|
Vision Screening | 2 | 2019 | 72 | 0.260 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1104 | 0.260 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2537 | 0.260 |
Why?
|
Deoxyguanosine | 3 | 2024 | 96 | 0.250 |
Why?
|
Prevalence | 13 | 2020 | 15835 | 0.250 |
Why?
|
Body Mass Index | 7 | 2022 | 13050 | 0.250 |
Why?
|
Urban Population | 1 | 2013 | 2040 | 0.250 |
Why?
|
Genetic Variation | 3 | 2019 | 6613 | 0.240 |
Why?
|
Gene Frequency | 3 | 2023 | 3624 | 0.240 |
Why?
|
Depression | 3 | 2018 | 8225 | 0.240 |
Why?
|
Age Factors | 11 | 2019 | 18397 | 0.230 |
Why?
|
Visually Impaired Persons | 2 | 2016 | 79 | 0.230 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7841 | 0.230 |
Why?
|
Neoplasms | 9 | 2023 | 22350 | 0.230 |
Why?
|
Antihypertensive Agents | 4 | 2017 | 2030 | 0.230 |
Why?
|
Homozygote | 3 | 2024 | 1775 | 0.230 |
Why?
|
Depressive Disorder, Major | 4 | 2021 | 4810 | 0.230 |
Why?
|
Overweight | 1 | 2015 | 2447 | 0.220 |
Why?
|
Netherlands | 3 | 2018 | 2277 | 0.220 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3250 | 0.220 |
Why?
|
Isocarboxazid | 1 | 2003 | 7 | 0.220 |
Why?
|
Obesity | 5 | 2022 | 13090 | 0.220 |
Why?
|
Somatotypes | 1 | 2023 | 39 | 0.210 |
Why?
|
Membrane Proteins | 6 | 2024 | 7869 | 0.210 |
Why?
|
Heart Rate | 6 | 2024 | 4207 | 0.210 |
Why?
|
Blood Pressure | 5 | 2020 | 8533 | 0.210 |
Why?
|
Disease Progression | 4 | 2022 | 13642 | 0.210 |
Why?
|
Follow-Up Studies | 9 | 2024 | 39312 | 0.200 |
Why?
|
Blood Coagulation | 2 | 2021 | 1163 | 0.200 |
Why?
|
Asthma | 2 | 2023 | 6266 | 0.200 |
Why?
|
Myocardial Infarction | 5 | 2022 | 11514 | 0.200 |
Why?
|
Vascular Diseases | 2 | 2021 | 1161 | 0.200 |
Why?
|
Atrioventricular Node | 1 | 2022 | 180 | 0.190 |
Why?
|
Nitriles | 2 | 2024 | 981 | 0.190 |
Why?
|
Dementia, Vascular | 1 | 2022 | 126 | 0.190 |
Why?
|
Alleles | 5 | 2020 | 6896 | 0.190 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 10384 | 0.190 |
Why?
|
DNA Damage | 4 | 2024 | 2469 | 0.190 |
Why?
|
Antithyroid Agents | 1 | 2021 | 72 | 0.190 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3411 | 0.180 |
Why?
|
Incidence | 6 | 2024 | 21527 | 0.180 |
Why?
|
Atrioventricular Block | 1 | 2023 | 141 | 0.180 |
Why?
|
Janus Kinase 1 | 1 | 2021 | 108 | 0.180 |
Why?
|
Platelet Activation | 1 | 2024 | 643 | 0.180 |
Why?
|
Interferons | 2 | 2022 | 716 | 0.180 |
Why?
|
Histocompatibility Antigens Class I | 5 | 2024 | 1362 | 0.180 |
Why?
|
Odds Ratio | 7 | 2019 | 9661 | 0.180 |
Why?
|
Appendectomy | 1 | 2024 | 445 | 0.170 |
Why?
|
Blood Coagulation Tests | 1 | 2021 | 269 | 0.170 |
Why?
|
Cholesterol, HDL | 5 | 2024 | 1814 | 0.170 |
Why?
|
Fibrinolysis | 1 | 2021 | 331 | 0.170 |
Why?
|
Fathers | 1 | 2023 | 377 | 0.170 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2021 | 276 | 0.170 |
Why?
|
Sleep | 1 | 2015 | 4814 | 0.170 |
Why?
|
Oxidation-Reduction | 4 | 2018 | 2221 | 0.170 |
Why?
|
Megakaryocytes | 1 | 2024 | 557 | 0.170 |
Why?
|
Biomedical Research | 1 | 2015 | 3459 | 0.160 |
Why?
|
Prospective Studies | 16 | 2024 | 54872 | 0.160 |
Why?
|
Lung | 1 | 2018 | 10068 | 0.160 |
Why?
|
Albumins | 1 | 2022 | 578 | 0.160 |
Why?
|
Proportional Hazards Models | 6 | 2024 | 12536 | 0.160 |
Why?
|
Blood Coagulation Factors | 1 | 2021 | 371 | 0.160 |
Why?
|
Erythrocyte Count | 1 | 2019 | 158 | 0.160 |
Why?
|
Pregnancy | 6 | 2021 | 30236 | 0.160 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2019 | 100 | 0.150 |
Why?
|
Erythropoiesis | 1 | 2022 | 692 | 0.150 |
Why?
|
Atrial Premature Complexes | 1 | 2018 | 17 | 0.150 |
Why?
|
Insulin-Secreting Cells | 2 | 2016 | 899 | 0.150 |
Why?
|
Blood Platelets | 3 | 2024 | 2465 | 0.150 |
Why?
|
Cohort Studies | 9 | 2024 | 41706 | 0.150 |
Why?
|
Mannose-Binding Lectin | 1 | 2019 | 146 | 0.150 |
Why?
|
Ankle Brachial Index | 1 | 2018 | 163 | 0.150 |
Why?
|
Risk | 6 | 2024 | 9602 | 0.150 |
Why?
|
Glaucoma, Open-Angle | 1 | 2024 | 742 | 0.150 |
Why?
|
Homocysteine | 1 | 2021 | 638 | 0.150 |
Why?
|
Leukocyte Count | 2 | 2019 | 1606 | 0.150 |
Why?
|
Neutrophils | 2 | 2024 | 3782 | 0.150 |
Why?
|
Kidney Function Tests | 1 | 2020 | 685 | 0.140 |
Why?
|
Risk Assessment | 8 | 2021 | 24299 | 0.140 |
Why?
|
von Willebrand Factor | 1 | 2021 | 680 | 0.140 |
Why?
|
Genetic Testing | 4 | 2022 | 3591 | 0.140 |
Why?
|
Recombinant Proteins | 2 | 2024 | 6507 | 0.140 |
Why?
|
Coronary Artery Disease | 3 | 2023 | 6575 | 0.140 |
Why?
|
Decompression, Surgical | 1 | 2022 | 603 | 0.140 |
Why?
|
Thyroid Diseases | 1 | 2020 | 385 | 0.140 |
Why?
|
Poverty Areas | 1 | 2018 | 268 | 0.140 |
Why?
|
Tumor Escape | 1 | 2020 | 371 | 0.140 |
Why?
|
Ventricular Premature Complexes | 1 | 2018 | 112 | 0.140 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 706 | 0.140 |
Why?
|
Islets of Langerhans | 1 | 2023 | 1350 | 0.140 |
Why?
|
Lymphocyte Count | 1 | 2019 | 794 | 0.130 |
Why?
|
Skin Diseases | 2 | 2016 | 1084 | 0.130 |
Why?
|
Receptors, Transferrin | 1 | 2018 | 300 | 0.130 |
Why?
|
Pyrazoles | 2 | 2024 | 2030 | 0.130 |
Why?
|
Stroke | 3 | 2022 | 9744 | 0.130 |
Why?
|
Quality of Life | 3 | 2020 | 13476 | 0.130 |
Why?
|
Athletic Performance | 1 | 2017 | 112 | 0.130 |
Why?
|
Comorbidity | 6 | 2023 | 10580 | 0.130 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2019 | 511 | 0.130 |
Why?
|
Superoxide Dismutase | 1 | 2019 | 596 | 0.130 |
Why?
|
Fertility | 1 | 2021 | 770 | 0.130 |
Why?
|
Drug Utilization | 2 | 2014 | 1188 | 0.130 |
Why?
|
Immunomodulation | 1 | 2020 | 548 | 0.130 |
Why?
|
Retrospective Studies | 10 | 2024 | 81657 | 0.130 |
Why?
|
Complement C3 | 1 | 2017 | 434 | 0.130 |
Why?
|
Magnesium | 1 | 2019 | 815 | 0.130 |
Why?
|
Models, Cardiovascular | 1 | 2021 | 978 | 0.130 |
Why?
|
Fever | 1 | 2003 | 1607 | 0.120 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14762 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2021 | 746 | 0.120 |
Why?
|
Interleukin-1 | 1 | 2019 | 1251 | 0.120 |
Why?
|
Vital Capacity | 1 | 2018 | 995 | 0.120 |
Why?
|
Zinc | 1 | 2019 | 675 | 0.120 |
Why?
|
Diabetic Retinopathy | 1 | 2024 | 1300 | 0.120 |
Why?
|
Cholesterol, LDL | 4 | 2022 | 2392 | 0.120 |
Why?
|
Potassium | 1 | 2019 | 1314 | 0.120 |
Why?
|
Physical Endurance | 1 | 2017 | 369 | 0.120 |
Why?
|
Pyrimidines | 2 | 2024 | 3043 | 0.120 |
Why?
|
Amino Acid Substitution | 1 | 2019 | 1742 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2158 | 0.120 |
Why?
|
C-Reactive Protein | 4 | 2022 | 3853 | 0.120 |
Why?
|
Mood Disorders | 1 | 2021 | 1127 | 0.120 |
Why?
|
Diet | 4 | 2019 | 8088 | 0.110 |
Why?
|
Heart Failure | 1 | 2018 | 11879 | 0.110 |
Why?
|
Cytokines | 2 | 2019 | 7438 | 0.110 |
Why?
|
Folic Acid | 1 | 2021 | 1337 | 0.110 |
Why?
|
Sex Factors | 6 | 2019 | 10619 | 0.110 |
Why?
|
5' Untranslated Regions | 1 | 2015 | 255 | 0.110 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2014 | 6020 | 0.110 |
Why?
|
Medicine | 1 | 2022 | 944 | 0.110 |
Why?
|
Waist Circumference | 1 | 2017 | 934 | 0.110 |
Why?
|
Brain Ischemia | 1 | 2007 | 3001 | 0.110 |
Why?
|
Urine | 1 | 2015 | 363 | 0.110 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2016 | 392 | 0.110 |
Why?
|
Estradiol | 1 | 2021 | 1947 | 0.110 |
Why?
|
Infant, Newborn, Diseases | 1 | 2019 | 587 | 0.110 |
Why?
|
Angina Pectoris | 1 | 2017 | 956 | 0.110 |
Why?
|
Area Under Curve | 1 | 2017 | 1639 | 0.110 |
Why?
|
Severity of Illness Index | 8 | 2019 | 15912 | 0.110 |
Why?
|
Gallstones | 1 | 2015 | 285 | 0.110 |
Why?
|
Random Allocation | 1 | 2017 | 2394 | 0.100 |
Why?
|
Physical Fitness | 1 | 2017 | 743 | 0.100 |
Why?
|
Forced Expiratory Volume | 1 | 2018 | 1828 | 0.100 |
Why?
|
Infant, Newborn | 7 | 2024 | 26387 | 0.100 |
Why?
|
Exons | 1 | 2019 | 2392 | 0.100 |
Why?
|
Age Distribution | 4 | 2014 | 2869 | 0.100 |
Why?
|
Demography | 1 | 2017 | 1641 | 0.100 |
Why?
|
Epidemics | 1 | 2018 | 516 | 0.100 |
Why?
|
Genetics, Population | 1 | 2017 | 943 | 0.100 |
Why?
|
Blood | 1 | 2015 | 598 | 0.100 |
Why?
|
Amblyopia | 1 | 2014 | 152 | 0.100 |
Why?
|
Microcirculation | 1 | 2017 | 1282 | 0.100 |
Why?
|
Thrombophilia | 1 | 2015 | 308 | 0.100 |
Why?
|
Health Services Research | 1 | 2020 | 1811 | 0.100 |
Why?
|
Quality Control | 1 | 2015 | 834 | 0.100 |
Why?
|
Self Care | 1 | 2017 | 800 | 0.100 |
Why?
|
Genetic Linkage | 1 | 2017 | 2342 | 0.100 |
Why?
|
Photography | 1 | 2015 | 536 | 0.100 |
Why?
|
Hemoglobins | 1 | 2018 | 1531 | 0.100 |
Why?
|
Immunologic Memory | 1 | 2019 | 1377 | 0.100 |
Why?
|
Autoimmunity | 2 | 2023 | 1361 | 0.100 |
Why?
|
Animals | 10 | 2021 | 168939 | 0.090 |
Why?
|
Epidemiologic Studies | 1 | 2015 | 677 | 0.090 |
Why?
|
Liver Neoplasms | 1 | 2007 | 4356 | 0.090 |
Why?
|
Mental Disorders | 2 | 2024 | 6869 | 0.090 |
Why?
|
Dietary Fats | 1 | 2019 | 2001 | 0.090 |
Why?
|
Research Design | 3 | 2017 | 6206 | 0.090 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2013 | 426 | 0.090 |
Why?
|
Sports | 1 | 2017 | 701 | 0.090 |
Why?
|
Spinal Fractures | 1 | 2018 | 702 | 0.090 |
Why?
|
Coronary Circulation | 1 | 2017 | 1602 | 0.090 |
Why?
|
Triglycerides | 2 | 2022 | 2441 | 0.090 |
Why?
|
Personality Inventory | 1 | 2014 | 1019 | 0.090 |
Why?
|
Adolescent | 10 | 2024 | 88902 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1949 | 0.090 |
Why?
|
Health Status | 1 | 2024 | 4087 | 0.090 |
Why?
|
Gestational Age | 1 | 2019 | 3617 | 0.090 |
Why?
|
Fluorescein Angiography | 1 | 2016 | 1086 | 0.090 |
Why?
|
Saliva | 1 | 2015 | 852 | 0.090 |
Why?
|
Length of Stay | 1 | 2024 | 6491 | 0.090 |
Why?
|
Testosterone | 1 | 2021 | 2495 | 0.080 |
Why?
|
Anticholesteremic Agents | 1 | 2017 | 970 | 0.080 |
Why?
|
Aortic Valve Stenosis | 1 | 2022 | 2023 | 0.080 |
Why?
|
Nutritional Status | 1 | 2018 | 1621 | 0.080 |
Why?
|
ROC Curve | 1 | 2017 | 3621 | 0.080 |
Why?
|
Alzheimer Disease | 2 | 2021 | 8715 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1805 | 0.080 |
Why?
|
Infertility, Female | 1 | 2015 | 763 | 0.080 |
Why?
|
Metalloendopeptidases | 2 | 2002 | 386 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2015 | 2350 | 0.080 |
Why?
|
Anthropometry | 1 | 2013 | 1336 | 0.080 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2971 | 0.080 |
Why?
|
Lumbar Vertebrae | 1 | 2018 | 1878 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6514 | 0.080 |
Why?
|
Vision Disorders | 1 | 2016 | 1090 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2014 | 935 | 0.080 |
Why?
|
Lipids | 1 | 2019 | 3322 | 0.080 |
Why?
|
Insulin | 3 | 2019 | 6608 | 0.080 |
Why?
|
Leukocytes | 1 | 2016 | 2034 | 0.070 |
Why?
|
Dietary Supplements | 2 | 2018 | 3429 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1925 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2210 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1445 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2024 | 14653 | 0.070 |
Why?
|
Physical Examination | 1 | 2013 | 1265 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2020 | 12064 | 0.070 |
Why?
|
Clinical Trials as Topic | 3 | 2021 | 8045 | 0.070 |
Why?
|
Dermatitis, Atopic | 1 | 2014 | 734 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15425 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2018 | 1304 | 0.070 |
Why?
|
Body Composition | 1 | 2015 | 2441 | 0.060 |
Why?
|
Calcium | 1 | 2019 | 5783 | 0.060 |
Why?
|
Anemia | 1 | 2015 | 1514 | 0.060 |
Why?
|
Vitamin D | 1 | 2019 | 3270 | 0.060 |
Why?
|
Asymptomatic Diseases | 2 | 2019 | 588 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2017 | 3563 | 0.060 |
Why?
|
Insulin Resistance | 2 | 2016 | 3989 | 0.060 |
Why?
|
Heart | 1 | 2018 | 4425 | 0.060 |
Why?
|
Pharmacogenetics | 1 | 2009 | 682 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2017 | 3208 | 0.060 |
Why?
|
Endpoint Determination | 1 | 2007 | 592 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5690 | 0.060 |
Why?
|
Retina | 1 | 2015 | 2660 | 0.060 |
Why?
|
Hospitals | 2 | 2015 | 3885 | 0.060 |
Why?
|
Hydrocortisone | 2 | 2022 | 1838 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3108 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3692 | 0.060 |
Why?
|
Stroke Volume | 1 | 2018 | 5618 | 0.060 |
Why?
|
Child | 6 | 2024 | 80670 | 0.050 |
Why?
|
Motor Activity | 1 | 2013 | 2711 | 0.050 |
Why?
|
Mass Screening | 1 | 2019 | 5454 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2255 | 0.050 |
Why?
|
Molecular Epidemiology | 1 | 2005 | 473 | 0.050 |
Why?
|
Heterozygote | 2 | 2007 | 2795 | 0.050 |
Why?
|
Estrogen Receptor alpha | 1 | 2007 | 581 | 0.050 |
Why?
|
Colon | 2 | 2002 | 1797 | 0.050 |
Why?
|
Prognosis | 2 | 2021 | 29959 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2018 | 3421 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2015 | 1883 | 0.050 |
Why?
|
Reference Values | 3 | 2021 | 4914 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2021 | 2921 | 0.050 |
Why?
|
Defense Mechanisms | 1 | 2022 | 178 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4853 | 0.050 |
Why?
|
Sex Determination Analysis | 1 | 2021 | 46 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2024 | 15831 | 0.050 |
Why?
|
Cities | 1 | 2024 | 542 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10263 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3683 | 0.050 |
Why?
|
Elastin | 1 | 2022 | 299 | 0.050 |
Why?
|
Histamine | 1 | 2022 | 496 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2021 | 405 | 0.040 |
Why?
|
Carotid Artery Diseases | 1 | 2007 | 872 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2013 | 4045 | 0.040 |
Why?
|
Family Health | 1 | 2005 | 1254 | 0.040 |
Why?
|
Heart Diseases | 2 | 2024 | 2817 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2016 | 4712 | 0.040 |
Why?
|
Intestinal Mucosa | 2 | 2002 | 3041 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2014 | 6214 | 0.040 |
Why?
|
Privacy | 1 | 2021 | 233 | 0.040 |
Why?
|
Anesthesia, Local | 1 | 2021 | 277 | 0.040 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2019 | 89 | 0.040 |
Why?
|
DNA | 2 | 2023 | 7210 | 0.040 |
Why?
|
Vasoconstrictor Agents | 1 | 2022 | 654 | 0.040 |
Why?
|
Tibial Arteries | 1 | 2018 | 60 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4114 | 0.040 |
Why?
|
Laboratories | 1 | 2022 | 463 | 0.040 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2021 | 354 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2022 | 988 | 0.040 |
Why?
|
Genomic Instability | 1 | 2022 | 716 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1123 | 0.040 |
Why?
|
Oculomotor Muscles | 1 | 2021 | 405 | 0.040 |
Why?
|
Competitive Behavior | 1 | 2017 | 77 | 0.030 |
Why?
|
Brachial Artery | 1 | 2018 | 373 | 0.030 |
Why?
|
Cicatrix | 1 | 2022 | 798 | 0.030 |
Why?
|
Water Supply | 1 | 2017 | 204 | 0.030 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2021 | 698 | 0.030 |
Why?
|
Infant | 3 | 2024 | 36459 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 1999 | 750 | 0.030 |
Why?
|
Immunity, Innate | 2 | 2019 | 3079 | 0.030 |
Why?
|
Visual Acuity | 2 | 2016 | 2714 | 0.030 |
Why?
|
Infant, Low Birth Weight | 1 | 2020 | 870 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2019 | 827 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2024 | 65286 | 0.030 |
Why?
|
Partial Thromboplastin Time | 1 | 2015 | 203 | 0.030 |
Why?
|
Neonatal Screening | 1 | 2019 | 619 | 0.030 |
Why?
|
Autopsy | 1 | 2018 | 1011 | 0.030 |
Why?
|
Teaching | 1 | 2022 | 1171 | 0.030 |
Why?
|
Suppuration | 1 | 2014 | 60 | 0.030 |
Why?
|
Unemployment | 1 | 2016 | 211 | 0.030 |
Why?
|
Antioxidants | 1 | 2022 | 1671 | 0.030 |
Why?
|
Death, Sudden, Cardiac | 1 | 2022 | 1567 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2003 | 1413 | 0.030 |
Why?
|
Hand Dermatoses | 1 | 2014 | 61 | 0.030 |
Why?
|
Bilirubin | 1 | 2015 | 440 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4349 | 0.030 |
Why?
|
Fundus Oculi | 1 | 2015 | 560 | 0.030 |
Why?
|
Calcinosis | 1 | 2022 | 1480 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2022 | 2140 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13276 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2015 | 382 | 0.030 |
Why?
|
Family Characteristics | 1 | 2018 | 1002 | 0.030 |
Why?
|
Epitopes | 1 | 2020 | 2526 | 0.030 |
Why?
|
China | 1 | 2019 | 2386 | 0.030 |
Why?
|
Diabetic Angiopathies | 1 | 2018 | 806 | 0.030 |
Why?
|
Microvessels | 1 | 2017 | 586 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 608 | 0.030 |
Why?
|
Immunity | 1 | 2019 | 1002 | 0.030 |
Why?
|
Sickness Impact Profile | 1 | 2014 | 299 | 0.030 |
Why?
|
Pruritus | 1 | 2016 | 378 | 0.030 |
Why?
|
Chronic Disease | 2 | 2020 | 9358 | 0.030 |
Why?
|
Bipolar Disorder | 2 | 2021 | 5130 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2015 | 855 | 0.030 |
Why?
|
Platelet Count | 1 | 2015 | 784 | 0.030 |
Why?
|
Serum Albumin | 1 | 2015 | 676 | 0.030 |
Why?
|
Blood Glucose | 2 | 2019 | 6422 | 0.020 |
Why?
|
Aortic Valve | 1 | 2022 | 1966 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 1998 | 0.020 |
Why?
|
Diet, Mediterranean | 1 | 2018 | 746 | 0.020 |
Why?
|
Hypertriglyceridemia | 1 | 2014 | 292 | 0.020 |
Why?
|
Obesity, Abdominal | 1 | 2014 | 372 | 0.020 |
Why?
|
Eczema | 1 | 2014 | 244 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2016 | 734 | 0.020 |
Why?
|
Central Nervous System | 1 | 2018 | 1345 | 0.020 |
Why?
|
Energy Intake | 1 | 2018 | 2142 | 0.020 |
Why?
|
Hypothalamus | 1 | 2016 | 1003 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2017 | 1312 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5873 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2002 | 1920 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2841 | 0.020 |
Why?
|
Lower Extremity | 1 | 2018 | 1217 | 0.020 |
Why?
|
Crohn Disease | 1 | 2002 | 2286 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1349 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6329 | 0.020 |
Why?
|
ADAM Proteins | 2 | 2002 | 243 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2614 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2274 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3226 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42577 | 0.020 |
Why?
|
Fasting | 1 | 2014 | 1609 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4652 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2144 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6258 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2015 | 1172 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2014 | 872 | 0.020 |
Why?
|
Disease | 1 | 2012 | 675 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5098 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5922 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20146 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40149 | 0.020 |
Why?
|
Homeostasis | 1 | 2016 | 3343 | 0.010 |
Why?
|
Inflammatory Bowel Diseases | 1 | 1999 | 2429 | 0.010 |
Why?
|
Aging | 1 | 2023 | 8728 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2008 | 21162 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2662 | 0.010 |
Why?
|
BRCA2 Protein | 1 | 2008 | 802 | 0.010 |
Why?
|
Skin | 1 | 2016 | 4499 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2008 | 1150 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 2007 | 678 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2596 | 0.010 |
Why?
|
Exercise | 1 | 2018 | 5945 | 0.010 |
Why?
|
Genital Neoplasms, Female | 1 | 2007 | 534 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8507 | 0.010 |
Why?
|
BRCA1 Protein | 1 | 2008 | 1155 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 14073 | 0.010 |
Why?
|
Estrogen Replacement Therapy | 1 | 2007 | 1204 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18329 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9514 | 0.010 |
Why?
|
Schizophrenia | 1 | 2018 | 6976 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22351 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13644 | 0.010 |
Why?
|
HLA Antigens | 1 | 2002 | 1339 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4249 | 0.010 |
Why?
|
Oligopeptides | 1 | 1999 | 1195 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4570 | 0.010 |
Why?
|
United States | 1 | 2019 | 72945 | 0.010 |
Why?
|
Colonoscopy | 1 | 1999 | 1409 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81898 | 0.010 |
Why?
|
Cell Membrane | 1 | 1999 | 3642 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2002 | 11062 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1999 | 13411 | 0.000 |
Why?
|
Biopsy | 1 | 1999 | 6779 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1999 | 17609 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1999 | 12795 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 11094 | 0.000 |
Why?
|